Empower Clinics Announces Proposal

Empower Clinics Announces Proposal For Division Spin Out VANCOUVER BC: August 1, 2023 – EMPOWER CLINICS INC. (CSE:EPW)(OTC PINK:EPWCF) (“Empower” or the “Company”) announces today, after a strategic review, the Company has determined that it intends to complete a direct spin out of a wholly owned subsidiary of the Company (“Subco”) and vend in a healthcare artificial intelligence (AI) technology or service company (the “Target”). The transaction is currently anticipated to proceed by way of...

read more

Empower Clinics Signs New Agreements

Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators – And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors Multiple Research Studies Are In Official Application Stage For EPW Curesearch Sites Covering Numerous Protocols And Specialties VANCOUVER, B.C.: July 31, 2023 – EMPOWER CLINICS INC (CSE:EPW) (OTCQB:EPWCF) ("Empower" or the "Company") a healthcare company with...

read more

Empower Clinics Provides Corporate Update

VANCOUVER, B.C.: May 19, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company with a developing research and clinical trials division announces various corporate updates. MAY 6, 2022 FILING DISCLOSURE UPDATE As a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure. The Company advises that the May 6, 2022 restated unaudited condensed interim consolidated...

read more